Syncom Formulations Intrinsic Value
Syncom Formulations intrinsic value. Syncom Formulations (SYNCOMF) median intrinsic value is ₹46.28 from 10 valuation models (range ₹7–₹58), vs current price ₹23.14 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit Syncom Formulations stock price NSE.
SYNCOMF Valuation Methods Summary — DCF, Graham Number & P/E
Syncom Formulations intrinsic value across 10 models vs current price ₹23.14 — upside/downside and value range per method. Compare with SYNCOMF DCF valuation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹23.76 | ₹19.01 - ₹28.51 | +2.7% | EPS: ₹1.08, Sector P/E: 22x |
| Book Value Method | asset | ₹57.85 | ₹52.07 - ₹63.64 | +150.0% | Book Value/Share: ₹44.15, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹46.28 | ₹41.65 - ₹50.91 | +100.0% | Revenue/Share: ₹63.83, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹46.28 | ₹41.65 - ₹50.91 | +100.0% | EBITDA: ₹148.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹57.85 | ₹46.28 - ₹69.42 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹6.94 | ₹6.25 - ₹7.63 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹16.69 | ₹15.02 - ₹18.36 | -27.9% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹46.28 | ₹41.65 - ₹50.91 | +100.0% | ROE: 24.1%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹32.75 | ₹29.48 - ₹36.03 | +41.5% | EPS: ₹1.08, BVPS: ₹44.15 |
| Dividend Yield Method | dividend | ₹6.94 | ₹6.25 - ₹7.63 | -70.0% | DPS: ₹0.10, Target Yield: 2.5% |
SYNCOMF Intrinsic Value vs Market Price — All Valuation Models
Syncom Formulations fair value range ₹7–₹58 vs current market price ₹23.14 across 10 valuation models. Read Syncom Formulations dividend policy for the complete payout history and dividend yield track record.
SYNCOMF Intrinsic Value Analysis — Undervalued or Overvalued?
Syncom Formulations median intrinsic value ₹46.28, current price ₹23.14 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of SYNCOMF?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Syncom Formulations (SYNCOMF) is ₹46.28 (median value). With the current market price of ₹23.14, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹6.94 to ₹57.85, indicating ₹6.94 - ₹57.85.
Is SYNCOMF undervalued or overvalued?
Based on our multi-method analysis, Syncom Formulations (SYNCOMF) appears to be trading below calculated value by approximately 100.0%.
SYNCOMF Financial Health — Key Ratios vs Industry Benchmarks
Syncom Formulations financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 22.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 24.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.12x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SYNCOMF Cash Flow Quality — Operating & Free Cash Flow
Syncom Formulations operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹58 Cr | ₹33 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹23 Cr | ₹14 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹11 Cr | ₹-12 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹16 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |